Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus subcutaneous erythropoietin in hemodialysis patients
IRCT20180124038491N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of erythropoietin in Uraemic Anaemia, sponsored by Mashhad University of Medical Sciences. Primary endpoints: Hematocrit and Hemoglobin. Started Apr 2018; status: completed.
02
Drugs
erythropoietin
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on IRCT20180124038491N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180124038491N1.